Malaria is one of the three major infectious diseases in the world today. According to estimates by The World Malaria Report 2018 issued by WHO, there were an estimated 219 million cases of malaria in 2017. Deaths reached 435,000. Most of the malaria cases occurred in the African region.
However, the investment to defeat malaria in 2017 is much lower than the investment needed for achieving the first milestone in the Global Technical Strategy for Malaria. The $3.1 billion investment in 2017 was only half of the goal (47%). Therefore, we established the BlueNet Foundation in the US, trying to make everyone know about prevention and treatment of malaria and encourage them to donate actively, raise funds to purchase more antimalarial drugs which will be deliver to Africa to save the lives from malaria by launching a charity composed of high school students as the main force to help malaria patients in Africa and by promoting the current situation of malaria transmission and the harm of malaria to humans.
Currently, we have established a non-profit organization in the US that has received federal tax exemption to help malaria patients in Africa, and we are working with our partners to raise money for this project that saves lives.
To rescue critical malaria patients, especially children, we work with medicine manufacturers, suppliers and hospitals, and deliver the purchased antimalarial drugs to Africa, providing opportunities for the patients to survive from severe malaria.
There were an estimated 219 million cases of malaria in 2017.
Most of the cases in 2017 were in the WHO African Region (92%), followed by the WHO South-East Asia Region ) and the WHO Eastern Mediterranean Region.
The Malaria patients in Ghana are 4% of those in the world.
P38, World Malaria Report 2018
Global deaths of Malaria reached 435,000 in 2017.
P42, World Malaria Report 2018
Malaria is caused by Plasmodium parasites. The parasites are spread to people through the bites of infected female Anopheles mosquitoes, called "malaria vectors." There are 5 parasite species that cause Malaria in humans, and 2 of these species – P. falciparum and P. vivax – pose the greatest threat.
Malaria is an acute febrile illness. In a non-immune individual, symptoms usually appear 10–15 days after the infective mosquito bite. The first symptoms – fever, headache, and chills – may be mild and difficult to recognize as malaria. If not treated within 24 hours, P. falciparum Malaria can progress to severe illness, often leading to death.
Children with severe Malaria frequently develop one or more of the following symptoms: severe anaemia, respiratory distress in relation to metabolic acidosis, or cerebral malaria. In adults, multi-organ failure is also frequent. In Malaria endemic areas, people may develop partial immunity, allowing asymptomatic infections to occur.
Reduce malaria mortality rates globally compared with 2015
2020: At least 40%
2025: At least 75%
2030: At least 90%
P1, World Malaria Report 2018